A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1997
10/16/1997	WO1997025071A3 Immunoconjugate for the treatment of aids
10/16/1997	WO1997024125A3 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol
10/16/1997	DE19613972A1 Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl Injection formulations of avermectins and milbemycins based on castor oil
10/16/1997	CA2251022A1 Oral coated active drugs
10/15/1997	EP0800830A2 Method of in vivo delivery of functioning foreign genes
10/15/1997	EP0800828A1 Transmucosal preparation
10/15/1997	EP0800821A2 Compositions comprising benzoyl peroxide and diethylene glycol monoethyl ether; method for their preparation
10/15/1997	EP0800588A1 Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support
10/15/1997	EP0800545A1 Targeted magnetically labeled molecular marker systems for the nmr imaging
10/15/1997	EP0800539A1 Novel cyclodextrin-derivatives and methods for the preparation thereof
10/15/1997	EP0800405A1 Continuous low-dose administration of parathyroid hormone or its agonist
10/15/1997	EP0800396A1 Treatment of hyperandrogenic conditions
10/15/1997	EP0800387A1 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours
10/15/1997	EP0800383A1 Proliposome powders for inhalation
10/15/1997	EP0800364A1 Transdermal administration of apomorphine
10/15/1997	CN1162335A Modified human C3 proteins
10/15/1997	CN1162267A Methods and compositions for specific coagulation of vasculature
10/15/1997	CN1162265A Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability and process for producing them
10/15/1997	CN1162262A Antiinflammatory agent for external use
10/15/1997	CN1162259A 药物组合物 The pharmaceutical composition of
10/15/1997	CN1162246A Ionene polymers containing biologically-active anions
10/14/1997	US5677445 Polycyclic complexing agents
10/14/1997	US5677437 Macromolecules; regulating rna expression; therapy
10/14/1997	US5677432 Immunological detection of organophosphates
10/14/1997	US5677427 Chimeric antibody for detection and therapy of infectious and inflammatory lesions
10/14/1997	US5677341 Mixture with lipid, nonionic surfactants and cholesterol
10/14/1997	US5677340 Method of using gluconic acid or gluconolactone for treating wrinkles
10/14/1997	US5677339 Method of using mandelic acid for treating wrinkles
10/14/1997	US5677284 Charged collagen particle-based delivery matrix
10/14/1997	US5677278 Truncated keratinocyte growth factor (KGF) having increased biological activity
10/14/1997	US5677274 Anthrax toxin fusion proteins and related methods
10/14/1997	US5677181 Antitumor, antiinflammatory agents
10/14/1997	US5677180 Chimeric antibody with specificity to human B cell surface antigen
10/14/1997	US5677171 Inhibit growth of sk-br-3 breast tumor cells
10/14/1997	US5677132 Using antibody; immunoassay of psychoactive drug
10/14/1997	US5676994 Non-separable starch-oil compositions
10/14/1997	US5676971 Agents for inhibiting adsorption of proteins on the liposome surface
10/14/1997	US5676970 Anti-inflammatory analgesic plaster
10/14/1997	US5676964 Crosslinked carboxy polysaccharides
10/14/1997	US5676963 Used for controlled release of nitric oxide to effect a desirable biological effect; antitumor agnet, treats cardiovascular disorders, coating of breast implant, reduces risk of metastasis
10/14/1997	US5676954 Administering by injection a nucleic acid-cationic liposome complex capable of functionally expressing the gene to the mammal at a site whereby target organ is the first organ having a capillary bed proximal to site of administeration
10/14/1997	US5676939 Polyamines and method for preparation thereof
10/14/1997	US5676930 Containing a medicine, a fluorohydrocarbon propellant, ethanol and either ascorbic or citric acid as stabilizer
10/14/1997	US5676929 Canister containing aerosol formulations containing P134a and particulate medicaments
10/11/1997	CA2173818A1 Time-released pharmaceutical compound containing a cured amylose-based support and hydroxypropylmethylcellulose
10/09/1997	WO1997037013A1 Asymmetric hammerhead ribozymes
10/09/1997	WO1997037005A1 Method for preventing hiv-1 infection of cd4+ cells
10/09/1997	WO1997036972A1 PROCESS FOR STABILISING AND DISPERSING VEGETABLE OILS WHICH CONTAIN POLYUNSATURATED FATTY ACID RADICALS BY MEANS OF η-CYCLODEXTRIN
10/09/1997	WO1997036949A1 Improved preparation method for biodegradable polymeric microspheres using solvent extraction and preparation method for microspheres for treating local inflammation using the same
10/09/1997	WO1997036948A1 Polymers containing cyclodextrin groups, process for their preparation and their use
10/09/1997	WO1997036935A1 Primycin compound with cyclodextrin
10/09/1997	WO1997036932A1 Modified/chimeric superantigens and their use
10/09/1997	WO1997036927A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors
10/09/1997	WO1997036911A1 Process for producing dissolved hard tissues and hard tissues thus dissolved
10/09/1997	WO1997036616A2 Anti-tumour agent
10/09/1997	WO1997036599A1 Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease
10/09/1997	WO1997036594A1 Vitamin b2-containing medicines
10/09/1997	WO1997036578A1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
10/09/1997	WO1997036574A1 Process and device for inhalation of particulate medicaments
10/09/1997	WO1997036555A1 Material for buffered resorbable internal fixation devices and method for making same
10/09/1997	WO1997036495A1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
10/09/1997	WO1997036485A1 Insecticidal combination effective against fleas on mammals, particularly cats and dogs
10/09/1997	WO1997036480A1 Compounds and compositions for delivering active agents
10/09/1997	WO1997030699A3 Dosage form of ibuprofen
10/09/1997	WO1997026864A3 Methods and compositions for enhancing the bioadhesive properties of polymers
10/09/1997	WO1997023240A3 Conjugate comprising an active agent, a polypeptide and a polyether
10/09/1997	WO1997021452A3 Macromolecular prodrugs of nucleotide analogs
10/09/1997	WO1997018840A3 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
10/09/1997	CA2250857A1 Asymmetric hammerhead ribozymes
10/09/1997	CA2250829A1 Method for preventing hiv-1 infection of cd4+ cells
10/09/1997	CA2250478A1 Spray-dried microparticles as therapeutic vehicles for use in gene therapy
10/09/1997	CA2250217A1 Process and device for inhalation of particulate medicaments
10/09/1997	CA2249459A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors
10/08/1997	EP0799059A1 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
10/08/1997	EP0799057A1 Targeting complexes and use thereof
10/08/1997	EP0799054A1 Conjugate for treating inflammatory diseases
10/08/1997	EP0799052A1 New antithrombotic formulation, process for its manufacturing, and use thereof
10/08/1997	EP0799047A1 Viscous liquid conditioning topical germicides
10/08/1997	EP0799046A1 Stable solutions of 2-chloro-2'-deoxyadenosine
10/08/1997	EP0799035A1 Emulsion suitable for administering a sphingolipid and use thereof
10/08/1997	EP0799030A1 Powder formulations containing melezitose as a diluent
10/08/1997	EP0799028A1 A controlled release formulation for poorly soluble basic drugs
10/08/1997	EP0799027A1 Liposomal interferon hybrid compositions
10/08/1997	EP0799026A1 Hemolysis prevention by surfactants and emulsions
10/08/1997	EP0799024A1 Pharmaceutical aerosol containing at least one sugar
10/08/1997	EP0777679A4 Delivery of nucleic acids
10/08/1997	EP0587554B1 A podophyllotoxin preparation containing triglycerides
10/08/1997	EP0568618B1 Polyose and fatty acid complex with high fatty acid content, use as emulsifying or moisturizing agent, and emulsifying or moisturizing composition containing it
10/08/1997	EP0544757B1 Novel polyamine conjugated oligonucleotides
10/08/1997	CN1161652A Pharmaceutical compositions
10/08/1997	CN1161337A Water soluble rapamycin esters
10/08/1997	CN1161233A Novel medicine for treating diseases of mouth or larynx, and process for mfg. same
10/07/1997	US5675062 Mouse engrafted with histoincompatible artery which exhibits detectable arteriosclerosis with in 30 days of grafting
10/07/1997	US5674980 Fusion protein comprising tat-derived transport moiety
10/07/1997	US5674977 Branched synthetic peptide conjugate
10/07/1997	US5674911 Administering therapeutic drug dispersed in polyoxyethylene-polyoxypropylene copolymer surfactant
10/07/1997	US5674903 Method of using citric acid for treating wrinkles
10/07/1997	US5674899 Method of using lactic acid for treating wrinkles
10/07/1997	US5674895 Time-released mixture containing oxybutynin or salt, polyalkylene oxide, hydroxypropylalkylcellulose, lubricant; drug delivery
10/07/1997	US5674874 Anticancer agent

1 ... 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 ... 1712